Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 c-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication.

× No keyword cloud information.

14 in total

Review 1. Glutamate transporters in neurologic disease.

Authors: N J Maragakis; J D Rothstein
Journal: Arch Neurol Date: 2001-03

2. Transplantation of GABAergic cell line as a novel hypothesized treatment for autism.

Authors: Ahmad Ghanizadeh
Journal: Epilepsy Behav Date: 2010-10-08 Impact factor: 2.937

3. Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.

Authors: Helmut Niederhofer
Journal: J Clin Psychopharmacol Date: 2007-06 Impact factor: 3.153

4. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

Authors: J D Rothstein; M Dykes-Hoberg; C A Pardo; L A Bristol; L Jin; R W Kuncl; Y Kanai; M A Hediger; Y Wang; J P Schielke; D F Welty
Journal: Neuron Date: 1996-03 Impact factor: 17.173

5. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument.

Authors: Masafumi Harada; Masako M Taki; Ayumi Nose; Hitoshi Kubo; Kenji Mori; Hiromu Nishitani; Tsuyoshi Matsuda
Journal: J Autism Dev Disord Date: 2011-04

6. Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis.

Authors: Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Sabrina Salani; Chiara Simone; Marianna Falcone; Giulietta Riboldi; Alessandra Govoni; Nereo Bresolin; Giacomo P Comi
Journal: Hum Mol Genet Date: 2010-07-22 Impact factor: 6.150

Review 7. Glutamate uptake.

Authors: N C Danbolt
Journal: Prog Neurobiol Date: 2001-09 Impact factor: 11.685

8. Increased serum levels of glutamate in adult patients with autism.

Authors: Atsuko Shinohe; Kenji Hashimoto; Kazuhiko Nakamura; Masatsugu Tsujii; Yasuhide Iwata; Kenji J Tsuchiya; Yoshimoto Sekine; Shiro Suda; Katsuaki Suzuki; Gen-Ichi Sugihara; Hideo Matsuzaki; Yoshio Minabe; Toshiro Sugiyama; Masayoshi Kawai; Masaomi Iyo; Nori Takei; Norio Mori
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2006-07-24 Impact factor: 5.067

9. Targeting neurotensin as a potential novel approach for the treatment of autism.

Authors: Ahmad Ghanizadeh
Journal: J Neuroinflammation Date: 2010-10-01 Impact factor: 8.322

10. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability.

Authors: Michael G Chez; Quinn Burton; Timothy Dowling; Mina Chang; Pavan Khanna; Christopher Kramer
Journal: J Child Neurol Date: 2007-05 Impact factor: 1.987

2 in total

1. Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.

Authors: Ahmad Ghanizadeh
Journal: Neurochem Res Date: 2011-01-06 Impact factor: 3.996

2. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors: Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal: BMC Psychiatry Date: 2013-07-25 Impact factor: 3.630

2 in total